相关实验视频
Updated: May 29, 2025

07:55
Pressure Controlled Ventilation to Induce Acute Lung Injury in Mice
Published on: May 5, 2011
18.2K
氧化应激对腺A2A受体活性和信号传递的影响
Idoia Company-Marín1, Joseph Gunner1, David Poyner1
1School of Biosciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK.
Biochimica et biophysica acta. Biomembranes
|February 5, 2025
概括
氧化应激不会改变腺A2A受体 (A2A R) 的结构,但可以通过调节其信号通路来减轻炎症,这表明一种恒温机制.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 氨酸A2A受体 (A2A R) 是一种具有抗炎性能的G蛋白结合受体,使其成为治疗点.
- 受体活性受到膜脂质的影响;烯酸 (SMA) 共聚合物在提取过程中保留脂质.
- 氧化应激对A2A R功能的影响仍然在很大程度上未被描述.
研究的目的:
- 研究氧化应激对腺A2A受体结构和功能的影响.
- 为了确定氧化应激是否影响A2A R连接体的结合和信号传递.
主要方法:
- 在Pichia pastoris中过度表达A2A R.
- 使用SMA共聚合物提取A2A R以保存原生脂质.
- 通过托芬光对联体诱导的形状变化的评估.
- 使用温度依赖测试对蛋白质展开的评估.
- 在氧化应激下测量表达A2A R的HEK293细胞中的cAMP水平.
主要成果:
- 通过SMA提取的A2A R表现出受氧化治疗 (AAPH,acrolein) 没有影响的联体诱导的形状变化.
- 氧化应激没有改变A2A R.的温度依赖蛋白质展开.
- 在HEK293细胞中,氧化应激增加了激动剂诱导的cAMP水平,但没有影响直接的腺酸环酶激活.
结论:
- 氧化应激不会直接影响腺A2A受体的结构完整性或带诱导的构造变化.
- 氧化应激可以作为一种恒温机制,通过调节A2A R信号通路来减少潜在的炎症.
相关概念视频
Adrenergic Receptors: ɑ Subtype
1.4K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.4K
Adrenergic Receptors: β Subtype
1.5K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.5K
Adrenergic Receptors (Adrenoceptors): Classification
2.2K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.2K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
531
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
531
Antihypertensive Drugs: Action of β1 Blockers
304
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
304
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
705
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
705

